Jaguar Health Inc
JAGX
Get informed when a big investor buys or sells
+ FollowMarket Cap$53.97K
Close$
$-0.98
241.6% downside
Current Fair Value
241.6% downsideOvervalued by 241.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $53,972.00 |
|---|---|
| Enterprise Value | $10.28 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-803.95 |
| Beta | -0.05 |
| Outstanding Shares | 809,122 |
Return
| Return on Equity | -552.34% |
|---|---|
| Return on Assets | -106.85% |
| Return on Invested Capital | -276.66% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | -0.01 |
| Price to Sales | 0.02 |
| Price to Book Ratio | 0.12 |
| Enterprise Value to Revenue | 0.37 |
| Enterprise Value to EBIT | -0.42 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.64 |
| Debt to Equity | 2.54 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 21, 2026
EPS Estimate
$-52.15
Average shareholder expectationRevenue Estimate
$4.24 M
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-40.95
Average shareholder expectationRevenue Estimate
$4.85 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.42%▲ 0.48% |
|---|---|
| Total Invested | $94,198▲ 53.54% |
| Investors Holding | 10▼ 1.00% |
ESG Score
No data
About Jaguar Health Inc
CEO: Lisa Conte